Tobramycin Inhalation Solution Inhalant
Product Images NDC 43598-605

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Tobramycin Inhalation Solution (NDC 43598-605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Line graph depicting average relative change in FEV1 % predicted over 24 weeks comparing Tobramycin Inhalation Solution and placebo in two studies. The x-axis shows weeks with treatment periods marked 'on drug.' The y-axis shows FEV1 change from -4 to 16%. Data series represent Study 1 and Study 2 for both Tobramycin and placebo groups, with sample sizes indicated.*

FDA Label Image

Figure2 (Figure2)

A line graph showing average change of Log10 CFUs over 24 weeks from two studies. It compares Tobramycin Inhalation Solution and placebo groups, indicating periods on drug at weeks 0-4, 8-12, and 16-20. The vertical axis measures average change of Log10 CFUs, and the horizontal axis represents weeks.*

FDA Label Image

Carton (Carton)

Packaging label for Tobramycin Inhalation Solution USP 300 mg/5 mL by Dr. Reddy's Laboratories Inc. The inhalant is for inhalation only by nebulizer, Rx only, containing 56 single-dose 5 mL ampules (28-day supply) with 4 ampules per pouch and 14 pouches per carton. Label includes storage instructions to keep the product refrigerated and notes that it contains no preservatives. Distributor and manufacturer details are printed alongside the barcode.*

FDA Label Image

Figa (Figa)

An instructional diagram showing components and setup for a nebulizer device used for inhalation therapy. Labeled parts include Air Compressor, Nebulizer Cup, Inspiratory Valve Cap, Mouthpiece, Ampule, Clean Paper or Cloth Towels, and Tubing, arranged on a surface to illustrate assembly and use.*

FDA Label Image

Figb (Figb)

An instructional illustration showing hands holding multiple single-dose ampules of Tobramycin Inhalation Solution 300 mg/5 mL. Arrows indicate the motion to separate the ampules from a connected strip and the steps to open each ampule for inhalation use.*

FDA Label Image

Figc (Figc)

An instructional illustration showing the proper method to open a Tobramycin Inhalation Solution ampule by snapping the top off at the marked score line. The diagram also points out the location on the ampule where the lot number and expiration date are printed.*

FDA Label Image

Figd (Figd)

An instructional illustration showing how to assemble a nebulizer device. It depicts a hand placing the nebulizer top onto the nebulizer cup. The diagram also labels the tubing, mouthpiece, and inspiratory valve cap components of the nebulizer setup.*

FDA Label Image

Fige (Fige)

An instructional diagram showing the insertion of a nebulizer insert into a nebulizer cup. A hand is depicted holding the nebulizer insert aligned above the nebulizer cup, with a curved arrow indicating the direction to insert the component downward into the cup.*

FDA Label Image

Figf (Figf)

An instructional illustration showing two parts of a nebulizer for inhalation solution use: a nebulizer top and a nebulizer cup. The components are placed on a clean paper or cloth towel surface, suggesting cleaning or assembly instructions.*

FDA Label Image

Figg (Figg)

Illustration showing a hand pulling a strip of Pulmo-Aide, a medical device used for respiratory therapy. The device is rectangular with a slot for the strip, which appears to be used for airflow or aerosol measurement.*

FDA Label Image

Figh (Figh)

An instructional illustration showing a hand holding an electrical plug, aligned and ready to be inserted into a standard two-socket wall outlet.*

FDA Label Image

Figi (Figi)

An instructional illustration showing hands opening a vial. The image demonstrates twisting the cap to remove it from the vial, with arrows indicating the direction to twist and lift the cap.*

FDA Label Image

Figj (Figj)

An instructional illustration showing a hand holding a dropper bottle positioned above a nebulizer cup. The dropper is releasing liquid into the top of the nebulizer, indicating the method of adding Tobramycin Inhalation Solution to the device for respiratory inhalation.*

FDA Label Image

Figk (Figk)

An instructional diagram illustrating the assembly of a nebulizer for inhalation use. It shows the nebulizer top, stem, semi-circle part, nebulizer outlet, and nebulizer cup. The sequence indicates attaching the nebulizer top over the nebulizer cup to form the complete nebulizer device.*

FDA Label Image

Figl (Figl)

An instructional illustration showing the assembly of a nebulizer for inhalation therapy. The diagram labels the mouthpiece, nebulizer outlet, and nebulizer cup, indicating the direction of airflow from the nebulizer cup through the outlet to the mouthpiece.*

FDA Label Image

Figm (Figm)

An illustration showing a respiratory inhalation device with a detachable inspiratory valve cap. Arrows indicate how to place the valve cap onto the top of the inhaler mouthpiece section.*

FDA Label Image

Fign (Fign)

An instructional diagram of a respiratory inhalation device for Tobramycin Inhalation Solution. The image highlights the air intake area and shows the device’s mouthpiece and connection point for the medication delivery system.*

FDA Label Image

Figo (Figo)

An instructional line drawing illustrating a hand pulling a tab on a carton, presumably to open the package. The carton shows a series of perforated circles near the top edge, indicating a tear strip for easy opening.*

FDA Label Image

Figp (Figp)

An instructional diagram illustrating the use of an inhalation device connected to a nebulizer cup, showing mist being emitted from the device mouthpiece. The image depicts the setup for administering an inhalant medication via a respiratory route.*

FDA Label Image

Figq (Figq)

An instructional diagram showing a person using a nebulizer for inhalation therapy. The illustration highlights the placement of a nose clip on the patient's nose as they inhale medication through a mouthpiece connected to the nebulizer device.*

FDA Label Image

Pouch (Pouch)

Label of Tobramycin Inhalation Solution USP 300 mg/5 mL by Dr. Reddy's Laboratories Inc. The inhalant comes in 4 single-dose 5 mL ampules per foil pouch, designated for inhalation only by nebulizer with no preservatives. Storage instructions specify refrigeration and the product is sterile, Rx only. The label includes manufacturer and distributor contact information and handling precautions.*

FDA Label Image

Singlecarton

Packaging label for Tobramycin Inhalation Solution, USP 300 mg/5 mL by Dr. Reddy's Laboratories Inc. The label specifies it is for inhalation only by nebulizer, sterile, contains no preservatives, and is for Rx use only. It contains 56 single-dose 5 mL ampules (one per pouch, 56 pouches per carton) with a 28-day supply. Storage instructions indicate to store in a refrigerator.*

FDA Label Image

Singlepouch

Label for Tobramycin Inhalation Solution USP 300 mg/5 mL ampules by Dr. Reddy's Laboratories Inc. The label specifies single-dose 5 mL ampules for inhalation use by nebulizer, containing no preservatives, stored refrigerated. Manufacturer information includes Holopack Verpackungstechnik GmbH, Germany, with distribution by Dr. Reddy's Laboratories in New Jersey, USA. The label features a barcode and contact phone number for more information.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Tobramycin, showing the molecular arrangement of atoms and functional groups in the active ingredient of Tobramycin Inhalation Solution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.